- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
回落整理中且下跌趋势有所减缓。
- 长期趋势：
已有3家主力机构披露2025-12-31报告期持股数据，持仓量总计171.42万股，占流通A股0.39%
- 波段诊断：
-
技术面诊股
诊断结果：6.2技术面打败了68%的股票
技术面评分前10的股票
近期的平均成本为41.48元。多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
平均成本
近期的平均成本为41.48元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"41.48","date":1770191801,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，接近行业平均水平。
[{"date":"2026.02.05","stock":"0.10","trade":null,"ind":"-1.44"},{"date":"2026.02.04","stock":"0.61","trade":null,"ind":"0.21"},{"date":"2026.02.03","stock":"1.01","trade":null,"ind":"2.19"},{"date":"2026.02.02","stock":"-2.02","trade":null,"ind":"-2.69"},{"date":"2026.01.30","stock":"-2.99","trade":null,"ind":"-0.66"},{"date":"2026.01.29","stock":"1.16","trade":null,"ind":"-0.30"},{"date":"2026.01.28","stock":"-3.64","trade":null,"ind":"0.09"},{"date":"2026.01.27","stock":"2.97","trade":null,"ind":"0.09"},{"date":"2026.01.26","stock":"0.78","trade":null,"ind":"-0.85"},{"date":"2026.01.23","stock":"2.99","trade":null,"ind":"0.79"},{"date":"2026.01.22","stock":"0.27","trade":null,"ind":"0.50"},{"date":"2026.01.21","stock":"0.17","trade":null,"ind":"0.70"},{"date":"2026.01.20","stock":"-1.09","trade":null,"ind":"-0.97"},{"date":"2026.01.19","stock":"-0.50","trade":null,"ind":"0.09"},{"date":"2026.01.16","stock":"-1.23","trade":null,"ind":"-0.18"},{"date":"2026.01.15","stock":"-1.29","trade":null,"ind":"0.41"},{"date":"2026.01.14","stock":"0.23","trade":null,"ind":"0.56"},{"date":"2026.01.13","stock":"0.69","trade":null,"ind":"-1.37"},{"date":"2026.01.12","stock":"1.34","trade":null,"ind":"1.75"},{"date":"2026.01.09","stock":"1.75","trade":null,"ind":"1.15"},{"date":"2026.01.08","stock":"0.37","trade":null,"ind":"-0.51"}]
九安医疗,深证成指,医疗器械指数
压力支撑
该股压力位为41.45元，支撑位为41.05元。
[{"text":"\u538b\u529b\u4f4d","value":"41.45","date":1770220800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"41.05","date":1770220800,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.1资金面打败了7%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：02月05日 20:30
| 机构今日流向(万元) | -599.16 | 机构5日流向(万元) | -3055.29 |
| 机构10日流向(万元) | -9780.61 | 机构20日流向(万元) | -18787.87 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少18064.51万股，其中基金净增仓1家，主力净减仓250家，暂未发现中长期投资价值。
截止2025-12-31，共3家主力机构（基金3家），持仓量总计171.42万股，占流通A股0.39%
其中，基金持仓与2025-06-30相比：
增仓：1家 ，增持 23.20万股
减仓：0家 ，减持 0万股
新出现在主力名单中：2家 ，持有109万股
从主力名单中消失：252家 ，原持有18196.71万股
其中，基金持仓与2025-06-30相比：
增仓：1家 ，增持 23.20万股
减仓：0家 ，减持 0万股
新出现在主力名单中：2家 ，持有109万股
从主力名单中消失：252家 ，原持有18196.71万股
消息面诊股
诊断结果：6.9消息面打败了74%的股票
今日有利好新闻的公司
近期该股利好消息较多，投资者可加强关注。
更多>>个股资讯
- 2025年中国互联网医疗行业政策、用户规模、市场规
2026-02-05 - 九安医疗：2月4日获融资买入3322.57万元
2026-02-05 - 业绩分化加剧！A股137家生物医药上市公司预亏
2026-02-02 - 九安医疗：自2025年起公司有序推进库存股的注销工
2026-02-02 - 最懂炒股的医疗公司？九安医疗：主业躺平，投资躺赢，
2026-01-30 - 44家大赚！179家医药企业净利润比拼（附名单）
2026-01-29 - 九安医疗获8家机构调研：公司正在积极加速推动糖尿病
2026-01-29 - 印度尼帕病毒点燃IVD“一日狂欢”：短炒退潮后，赛
2026-01-29 - 基金1月28日参与23家公司的调研活动
2026-01-29 - 九安医疗：1月28日接受机构调研，农银汇理、南方基
2026-01-29
消息列表
| 利好 | 业绩预告 | 业绩预增 | 2026-01-27 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-12-15 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-11-29 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-27 |
| 利好 | 分红转增 | 10派2元(含税) | 2025-04-29 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：3.5行业面打败了55%的股票
医疗器械行业最新资金流向
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
[{"date":"2026.02.05","price":"-1.44","value":null},{"date":"2026.02.04","price":"0.21","value":null},{"date":"2026.02.03","price":"2.19","value":null},{"date":"2026.02.02","price":"-2.69","value":null},{"date":"2026.01.30","price":"-0.66","value":null},{"date":"2026.01.29","price":"-0.30","value":null},{"date":"2026.01.28","price":"0.09","value":null},{"date":"2026.01.27","price":"0.09","value":null},{"date":"2026.01.26","price":"-0.85","value":null},{"date":"2026.01.23","price":"0.79","value":null},{"date":"2026.01.22","price":"0.50","value":null},{"date":"2026.01.21","price":"0.70","value":null},{"date":"2026.01.20","price":"-0.97","value":null},{"date":"2026.01.19","price":"0.09","value":null},{"date":"2026.01.16","price":"-0.18","value":null},{"date":"2026.01.15","price":"0.41","value":null},{"date":"2026.01.14","price":"0.56","value":null},{"date":"2026.01.13","price":"-1.37","value":null},{"date":"2026.01.12","price":"1.75","value":null},{"date":"2026.01.09","price":"1.15","value":null},{"date":"2026.01.08","price":"-0.51","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 华兰股份 | 69.73% | 3.50% | 6.2分 |
| 2 | 宝莱特 | 48.57% | 4.32% | 4.9分 |
| 3 | 天智航 | 38.68% | 2.37% | 5.7分 |
| 4 | 西山科技 | 30.58% | 7.86% | 6.5分 |
| 5 | 康众医疗 | 24.02% | -9.55% | 4.2分 |
| 6 | 凯普生物 | 22.44% | -12.72% | 4.6分 |
| 8 | 国发股份 | 17.46% | 3.79% | 5.9分 |
| 10 | 奕瑞科技 | 11.56% | 2.01% | 6.1分 |
| 12 | 维力医疗 | 11.22% | 2.53% | 6.0分 |
| 14 | 洁特生物 | 9.56% | 2.23% | 5.8分 |
| 16 | 东星医疗 | 8.59% | 1.48% | 4.6分 |
| 18 | 山外山 | 8.28% | 4.32% | 6.7分 |
| 20 | 黄山胶囊 | 7.64% | 3.75% | 6.1分 |
| 22 | 南卫股份 | 6.32% | 6.32% | 6.0分 |
| 24 | 戴维医疗 | 5.85% | 3.10% | 6.0分 |
| 26 | 天益医疗 | 5.40% | -2.00% | 4.6分 |
| 28 | 理邦仪器 | 4.48% | -1.63% | 5.7分 |
| 30 | 康德莱 | 4.38% | 0.87% | 6.0分 |
| 32 | 昊海生科 | 4.31% | 2.37% | 5.9分 |
| 34 | 英科医疗 | 4.25% | 0.32% | 4.4分 |
| 36 | 三鑫医疗 | 3.97% | 2.50% | 5.2分 |
| 38 | 采纳股份 | 3.16% | 5.17% | 4.5分 |
| 40 | 心脉医疗 | 2.61% | 4.78% | 6.4分 |
| 42 | 圣湘生物 | 2.51% | -0.99% | 5.0分 |
| 44 | 万孚生物 | 2.38% | -5.36% | 3.7分 |
| 46 | 山东药玻 | 2.08% | 0.10% | 5.5分 |
| 48 | 之江生物 | 1.95% | -6.81% | 4.8分 |
| 50 | 科美诊断 | 1.81% | -1.13% | 3.7分 |
| 52 | 科华生物 | 1.31% | -4.47% | 3.5分 |
| 54 | 健帆生物 | 1.22% | 1.62% | 5.1分 |
| 56 | 尚荣医疗 | 1.05% | 1.32% | 5.0分 |
| 58 | 麦克奥迪 | 1.01% | -0.59% | 4.0分 |
| 60 | - | 0.97% | -2.90% | 分 |
| 62 | 港通医疗 | 0.82% | 7.94% | 5.3分 |
| 64 | 振德医疗 | 0.76% | 4.64% | 5.9分 |
| 66 | 安必平 | 0.69% | -1.00% | 4.7分 |
| 68 | 美康生物 | 0.59% | -0.78% | 4.1分 |
| 70 | 迪瑞医疗 | 0.53% | -1.70% | 4.1分 |
| 72 | 艾德生物 | 0.14% | -2.74% | 4.4分 |
| 74 | 易瑞生物 | -0.41% | -1.22% | 5.0分 |
| 76 | 中红医疗 | -0.92% | -0.15% | 4.8分 |
| 78 | 安旭生物 | -0.92% | -1.63% | 4.1分 |
| 80 | 康为世纪 | -1.19% | -4.56% | 4.6分 |
| 82 | 安杰思 | -1.68% | -0.49% | 5.4分 |
| 84 | 康泰医学 | -1.77% | -0.77% | 4.6分 |
| 86 | 华大智造 | -1.98% | -1.04% | 5.5分 |
| 88 | 威高血净 | -2.42% | -0.57% | 5.6分 |
| 90 | 东方生物 | -2.92% | -3.88% | 4.2分 |
| 92 | 万东医疗 | -3.49% | 0.69% | 5.0分 |
| 94 | 佰仁医疗 | -4.11% | -1.08% | 5.5分 |
| 96 | 迈瑞医疗 | -4.76% | -0.66% | 5.2分 |
| 98 | 中源协和 | -5.00% | -2.64% | 4.5分 |
| 100 | 开立医疗 | -5.48% | -1.09% | 4.6分 |
| 102 | 超研股份 | -5.86% | -0.40% | 5.5分 |
| 104 | - | -6.38% | -2.55% | 分 |
| 106 | 春立医疗 | -6.70% | -8.40% | 5.3分 |
| 108 | 奥美医疗 | -6.95% | -10.19% | 3.8分 |
| 110 | 亚辉龙 | -8.10% | -0.27% | 4.5分 |
| 112 | 乐普医疗 | -8.86% | -2.72% | 5.6分 |
| 114 | 冠昊生物 | -9.22% | -4.13% | 5.0分 |
| 116 | 济民健康 | -9.51% | 3.43% | 4.3分 |
| 118 | 瑞迈特 | -9.87% | 1.68% | 5.8分 |
| 120 | 惠泰医疗 | -10.23% | -1.97% | 5.3分 |
| 122 | 新产业 | -11.00% | 0.91% | 5.0分 |
| 124 | 天臣医疗 | -13.13% | -0.87% | 5.8分 |
| 126 | 伟思医疗 | -16.49% | 0.52% | 5.5分 |
| 128 | 海利生物 | -18.82% | -20.79% | 3.9分 |
| 130 | 麦澜德 | -19.92% | -1.78% | 5.6分 |
| 132 | 博拓生物 | -22.73% | -2.65% | 4.6分 |
| 134 | 热景生物 | -29.07% | -5.19% | 3.6分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 30/247 ， 37/247。
[{"date":"2025-09-30","value":"7.40","vol":"2.98"},{"date":"2025-06-30","value":"4.33","vol":"2.34"},{"date":"2025-03-31","value":"1.26","vol":"1.16"},{"date":"2024-12-31","value":"8.35","vol":"0.56"},{"date":"2024-09-30","value":"7.11","vol":"4.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
7.40 | 4.33 | 1.26 | 8.35 | 7.11 |
| 行业(%) | 2.98 | 2.34 | 1.16 | 0.56 | 4.64 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"65.40","vol":"51.73"},{"date":"2025-06-30","value":"66.18","vol":"52.04"},{"date":"2025-03-31","value":"70.46","vol":"51.41"},{"date":"2024-12-31","value":"70.67","vol":"52.51"},{"date":"2024-09-30","value":"71.68","vol":"53.36"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
65.40 | 66.18 | 70.46 | 70.67 | 71.68 |
| 行业(%) | 51.73 | 52.04 | 51.41 | 52.51 | 53.36 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 128/247 ， 42/247。
[{"date":"2025-09-30","value":"-48.89","vol":"0.24"},{"date":"2025-06-30","value":"-43.35","vol":"-1.07"},{"date":"2025-03-31","value":"-33.49","vol":"-0.10"},{"date":"2024-12-31","value":"-19.77","vol":"1.15"},{"date":"2024-09-30","value":"-23.79","vol":"0.77"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-48.89 | -43.35 | -33.49 | -19.77 | -23.79 |
| 行业(%) | 0.24 | -1.07 | -0.10 | 1.15 | 0.77 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"16.11","vol":"-15.37"},{"date":"2025-06-30","value":"52.91","vol":"-18.14"},{"date":"2025-03-31","value":"7.62","vol":"-2.59"},{"date":"2024-12-31","value":"33.33","vol":"-23.09"},{"date":"2024-09-30","value":"52.63","vol":"-19.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
16.11 | 52.91 | 7.62 | 33.33 | 52.63 |
| 行业(%) | -15.37 | -18.14 | -2.59 | -23.09 | -19.92 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 128/247 ， 45/247。
[{"date":"2025-09-30","value":"0.04","vol":"0.25"},{"date":"2025-06-30","value":"0.03","vol":"0.17"},{"date":"2025-03-31","value":"0.02","vol":"0.08"},{"date":"2024-12-31","value":"0.11","vol":"0.36"},{"date":"2024-09-30","value":"0.09","vol":"0.26"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.04 | 0.03 | 0.02 | 0.11 | 0.09 |
| 行业(次) | 0.25 | 0.17 | 0.08 | 0.36 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.83","vol":"1.66"},{"date":"2025-06-30","value":"1.41","vol":"1.12"},{"date":"2025-03-31","value":"0.79","vol":"0.55"},{"date":"2024-12-31","value":"3.02","vol":"2.32"},{"date":"2024-09-30","value":"2.37","vol":"1.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.83 | 1.41 | 0.79 | 3.02 | 2.37 |
| 行业(次) | 1.66 | 1.12 | 0.55 | 2.32 | 1.64 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"-16.55","vol":"14.75"},{"date":"2025-06-30","value":"3.46","vol":"15.16"},{"date":"2025-03-31","value":"1.44","vol":"4.21"},{"date":"2024-12-31","value":"58.32","vol":"29.34"},{"date":"2024-09-30","value":"44.57","vol":"15.46"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -16.55 | 3.46 | 1.44 | 58.32 | 44.57 |
| 行业 | 14.75 | 15.16 | 4.21 | 29.34 | 15.46 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"1.73","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.09","vol":"2.17"},{"date":"2024-09-30","value":"","vol":"0.01"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.73 | - | 1.09 | - |
| 行业 | 0.01 | 1.57 | 0.00 | 2.17 | 0.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 71/247 ， 84/247。
[{"date":"2025-09-30","value":"4.77","vol":"5.66"},{"date":"2025-06-30","value":"3.43","vol":"5.47"},{"date":"2025-03-31","value":"4.41","vol":"5.84"},{"date":"2024-12-31","value":"5.50","vol":"5.30"},{"date":"2024-09-30","value":"7.92","vol":"5.83"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
4.77 | 3.43 | 4.41 | 5.50 | 7.92 |
| 行业 | 5.66 | 5.47 | 5.84 | 5.30 | 5.83 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"4.41","vol":"4.51"},{"date":"2025-06-30","value":"2.56","vol":"4.35"},{"date":"2025-03-31","value":"3.21","vol":"4.73"},{"date":"2024-12-31","value":"4.14","vol":"4.27"},{"date":"2024-09-30","value":"6.02","vol":"4.70"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
4.41 | 2.56 | 3.21 | 4.14 | 6.02 |
| 行业 | 4.51 | 4.35 | 4.73 | 4.27 | 4.70 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 53/247 ， 54/247。
[{"date":"2025-09-30","value":"22.64","vol":"22.07"},{"date":"2025-06-30","value":"23.10","vol":"22.01"},{"date":"2025-03-31","value":"18.66","vol":"21.19"},{"date":"2024-12-31","value":"18.40","vol":"21.94"},{"date":"2024-09-30","value":"18.16","vol":"20.60"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
22.64 | 23.10 | 18.66 | 18.40 | 18.16 |
| 行业(%) | 22.07 | 22.01 | 21.19 | 21.94 | 20.60 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.30","vol":"0.71"},{"date":"2025-06-30","value":"0.30","vol":"0.58"},{"date":"2025-03-31","value":"0.23","vol":"0.56"},{"date":"2024-12-31","value":"0.23","vol":"0.55"},{"date":"2024-09-30","value":"0.23","vol":"0.37"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.30 | 0.30 | 0.23 | 0.23 | 0.23 |
| 行业(%) | 0.71 | 0.58 | 0.56 | 0.55 | 0.37 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"9.09","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"160.30","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"12.52","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"16.69","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"23.41","blueLineValue":"5.04","type":"YC"}]